|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.28 USD | -4.41% |
|
-1.72% | +1.45% |
| Apr. 19 | Lifecore Biomedical Gets Nasdaq Warning Over Delayed Quarterly Report | MT |
| Apr. 01 | Lifecore Biomedical, Inc. Provides Revenue Guidance for Full Year Fiscal 2024 | CI |
Lifecore Biomedical, Inc. announced in connection with the issuance of the Series A convertible preferred stock, Nathaniel Calloway, PhD and Christopher Kiper were appointed to the company's Board of Directors.
| 1st Jan change | Capi. | |
|---|---|---|
| +1.45% | 192M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
LIFECORE BIOMEDICAL, INC. 
